These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12367582)
21. [Refractory thrombotic thrombocytopenic purpura successfully treated with a combination of rituximab and vincristine]. Kaneko H; Matsumoto M; Okamoto K; Chyonabayashi K; Hishizawa M; Watanabe M; Fujimura Y; Tsudo M Rinsho Ketsueki; 2007 Feb; 48(2):144-7. PubMed ID: 17370643 [TBL] [Abstract][Full Text] [Related]
22. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection. Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376 [TBL] [Abstract][Full Text] [Related]
23. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab. Goyal J; Adamski J; Lima JL; Marques MB J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472 [TBL] [Abstract][Full Text] [Related]
24. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715 [TBL] [Abstract][Full Text] [Related]
25. Summaries for patients. Treatment of refractory thrombotic thrombocytopenic purpura. Ann Intern Med; 2003 Jan; 138(2):I38. PubMed ID: 12529111 [No Abstract] [Full Text] [Related]
26. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child. Jayabose S; Dunbar J; Nowicki TS; Tugal O; Ozkaynak MF; Sandoval C Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972 [TBL] [Abstract][Full Text] [Related]
27. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362 [TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab. Chemnitz JM; Uener J; Hallek M; Scheid C Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413 [TBL] [Abstract][Full Text] [Related]
29. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays. McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997 [TBL] [Abstract][Full Text] [Related]
30. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib. van Balen T; Schreuder MF; de Jong H; van de Kar NC Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335 [TBL] [Abstract][Full Text] [Related]
31. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor. Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026 [TBL] [Abstract][Full Text] [Related]
32. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919 [TBL] [Abstract][Full Text] [Related]
33. Rituximab for TTP. Scott SM; Szczepiorkowski ZM Am J Hematol; 2005 Sep; 80(1):87-8. PubMed ID: 16138332 [No Abstract] [Full Text] [Related]
34. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Hull MJ; Eichbaum QG Clin Adv Hematol Oncol; 2006 Mar; 4(3):210-4; discussion 217-8. PubMed ID: 16728930 [No Abstract] [Full Text] [Related]
35. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura. Coppo P; Veyradier A Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954 [TBL] [Abstract][Full Text] [Related]
36. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Bhagirath VC; Kelton JG; Moore J; Arnold DM Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316 [TBL] [Abstract][Full Text] [Related]
37. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report. Yates S; Matevosyan K; Rutherford C; Shen YM; Sarode R Transfusion; 2014 Aug; 54(8):2064-7. PubMed ID: 24655327 [TBL] [Abstract][Full Text] [Related]
38. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Mori Y; Wada H; Gabazza EC; Minami N; Nobori T; Shiku H; Yagi H; Ishizashi H; Matsumoto M; Fujimura Y Transfusion; 2002 May; 42(5):572-80. PubMed ID: 12084165 [TBL] [Abstract][Full Text] [Related]
39. Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. Hie M; Gay J; Galicier L; Provôt F; Presne C; Poullin P; Bonmarchand G; Wynckel A; Benhamou Y; Vanhille P; Servais A; Bordessoule D; Coindre JP; Hamidou M; Vernant JP; Veyradier A; Coppo P; Blood; 2014 Jul; 124(2):204-10. PubMed ID: 24869941 [TBL] [Abstract][Full Text] [Related]